HIVE stock forecast, quote, news & analysis
HIVE Digital Technologies Ltd is a sustainable-energy-focused digital infrastructure company that provides infrastructure solutions through the operation of Tier-1 and Tier-3 data centers... Show more
Why HIVE Digital Technologies (HIVE) Stock Is Down -28.6% in the Last 30 Days
Key Takeaways
- HIVE shares declined approximately 28.6% over the past 30 days, retreating from a year-to-date high of $5.34 reached on June 22 to around $3.24 as of early July.
- The pullback followed a massive rally driven by a landmark $220 million sovereign AI GPU cloud contract with Bell Canada and Cohere, announced on June 18.
- An upsized $115 million convertible note offering priced on June 25 triggered dilution concerns and accelerated profit-taking among short-term traders.
- Despite the 30-day decline, HIVE remains up roughly 69% over the full quarter, reflecting a broader transformation from a pure-play Bitcoin miner into an AI and high-performance computing infrastructure company.
- Analyst sentiment remains broadly positive, with Cantor Fitzgerald, B. Riley, and Rosenblatt all raising price targets following the AI contract announcement.
HIVE Digital Technologies (HIVE) Company Overview and Market Position
HIVE Digital Technologies Ltd. is a data center and digital infrastructure company that operates across Canada, Sweden, and Paraguay. Founded in 2017 as one of the first publicly listed cryptocurrency miners powered by green energy, HIVE has since evolved into a dual-engine business: it maintains a substantial Bitcoin mining operation while aggressively expanding into high-performance computing (HPC) and artificial intelligence cloud services. Through its wholly owned subsidiary BUZZ High Performance Computing Inc., the company deploys NVIDIA GPU clusters for enterprise AI workloads, sovereign cloud infrastructure, and large-scale model training. This pivot has repositioned HIVE from a crypto-beta name into an emerging AI infrastructure landlord, attracting a new class of institutional investors focused on compute scarcity and data center capacity.
HIVE Digital Technologies (HIVE) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, HIVE shares experienced a sharp reversal. The stock closed at $4.54 on June 2 and surged to a year-to-date peak of $5.34 on June 22, fueled by the blockbuster $220 million AI infrastructure deal. However, the rally proved unsustainable. By July 2, shares had fallen to approximately $3.24, representing a decline of roughly 28.6% from the June 2 close. The selloff intensified after the company announced a $115 million convertible note offering, which raised concerns about shareholder dilution and near-term capital structure pressure.
Zooming out to the quarterly view paints a different picture. At the start of April, HIVE traded near $1.92. The stock more than doubled over the following weeks, driven by accelerating HPC revenue, data center expansion news, and growing recognition of the company's AI pivot. Even after the recent pullback, HIVE remains up approximately 69% for the quarter, underscoring that the 30-day decline is largely a correction within a broader uptrend.
What Drove HIVE Stock Price in the Last 30 Days
The dominant catalyst during this period was the June 18 announcement that BUZZ HPC had signed a three-year, $220 million sovereign AI GPU cloud contract with Bell Canada and Cohere Inc. The deal involves deploying 2,304 NVIDIA Grace Blackwell GPUs at Bell's facility in Merritt, British Columbia, creating a Canadian sovereign AI stack for enterprise and government customers. HIVE shares jumped over 10% in pre-market trading on the news and continued climbing in subsequent sessions, reaching $5.34 on June 22.
Simultaneously, HIVE disclosed that the Boden Municipal Council in Sweden had approved its acquisition of the 32-megawatt Big Boden data center, a facility the company had operated as a tenant since 2018. A subsequent letter of intent with a Swedish sovereign technology company for a potential 10-year lease added further momentum.
The reversal began in earnest on June 25, when HIVE priced an upsized $115 million zero-coupon exchangeable senior notes offering due 2031, increased from an initially planned $100 million. The notes carry an exchange price of approximately $4.83 per share, and the company entered capped call transactions to mitigate dilution. Despite these protections, the offering reminded the market of the capital-intensive nature of HIVE's AI buildout and triggered a wave of profit-taking after the stock's rapid ascent. Broader weakness in Bitcoin prices during late June also weighed on sentiment, given HIVE's continued exposure to crypto mining revenue.
What Drove HIVE Stock Performance Over the Last Quarter
The quarterly surge was powered by a fundamental narrative shift. HIVE reported fiscal 2026 revenue of $297.8 million, up 158% year-over-year, including a record $19.5 million from its HPC business. The company scaled its Bitcoin hashrate from 6.5 EH/s to 25.1 EH/s while simultaneously building out GPU cloud infrastructure. The $220 million Bell-Cohere contract validated the HPC strategy and gave analysts concrete revenue visibility, with management projecting contracted HPC annual recurring revenue targets above $100 million once the GB200 systems go live. Multiple analyst upgrades followed, with price targets rising to as high as $8 at B. Riley. The combination of triple-digit revenue growth, tangible AI contracts, and expanding data center assets drove the stock's quarterly outperformance, even as the final weeks brought a sharp correction.
Trending AI Robots
In a market environment where AI-driven infrastructure stocks like HIVE can swing dramatically on contract news and capital raises, traders are increasingly turning to automated strategies to navigate volatility. Tickeron's Trending AI Robots page showcases a curated selection of top-performing AI trading bots from a universe of hundreds that trade thousands of tickers across equities, ETFs, and cryptocurrencies. These bots employ diverse strategies, timeframes, and risk profiles, and only the most relevant and consistently performing robots appear in this section. Whether you are looking for short-term momentum plays or longer-duration trend-following approaches, exploring the Trending AI Robots page can help you identify data-driven tools aligned with your trading objectives.
HIVE Stock Forecast Drivers: What Investors Should Watch Next
Looking ahead, the key variable for HIVE is execution on the $220 million Bell-Cohere deployment. The GB200 GPU cluster is expected to enter service between late 2026 and early 2027, and any updates on timeline, capital expenditures, or additional customer commitments will be closely scrutinized. The finalization of the Swedish Boden lease agreement and progress on the 100-megawatt Paraguay substation project represent additional catalysts. On the risk side, Bitcoin price volatility remains a factor, as mining still contributes a material portion of revenue. The convertible note overhang and potential future equity raises under the company's $300 million at-the-market program could also influence trading dynamics. Analysts will be watching for continued HPC revenue growth, margin improvement, and evidence that HIVE can convert its infrastructure pipeline into long-term, recurring cash flows.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
HIVE's RSI Oscillator leaves overbought zone
The 10-day RSI Indicator for HIVE moved out of overbought territory on June 23, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 instances where the indicator moved out of the overbought zone. In of the 37 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for HIVE turned negative on June 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
HIVE broke above its upper Bollinger Band on June 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Momentum Indicator moved above the 0 level on July 02, 2026. You may want to consider a long position or call options on HIVE as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The 50-day moving average for HIVE moved above the 200-day moving average on June 23, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where HIVE advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 203 cases where HIVE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HIVE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.475) is normal, around the industry mean (4.088). P/E Ratio (9.174) is within average values for comparable stocks, (48.334). HIVE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.857). Dividend Yield (0.000) settles around the average of (0.034) among similar stocks. P/S Ratio (3.709) is also within normal values, averaging (32.214).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of cloud networking and enterprise Wi-Fi solution
Industry InvestmentBanksBrokers